Bicalutamide 150 mg: Practical prescribing in patients with early prostate cancer

被引：2
|
作者：
Anderson, J [1 ]
机构：
[1] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England
来源：
BJU INTERNATIONAL | 2004年 / 94卷 / 06期
关键词：
D O I：
10.1111/j.1464-410X.2004.05066.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：758 / 759
页数：2
相关论文
共 50 条
  • [1] Effect of bicalutamide 150 mg on PSA progression in MO prostate cancer: Results from the Early Prostate Cancer program.
    See, W. A.
    McLeod, D. G.
    Iversen, P.
    Wirth, M. P.
    Armstrong, J.
    Navani, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 247S - 247S
  • [2] Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme
    Tyrrell, CJ
    Payne, H
    See, WA
    McLeod, DG
    Wirth, MP
    Iversen, P
    Armstrong, J
    Morris, C
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 (01) : 4 - 10
  • [3] Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
    McLeod, DG
    Iversen, P
    See, WA
    Morris, T
    Armstrong, J
    Wirth, MP
    BJU INTERNATIONAL, 2006, 97 (02) : 247 - 254
  • [4] Spotlight on bicalutamide 150mg in the treatment of locally advanced prostate cancer
    Wellington, Keri
    Keam, Susan J.
    DRUGS & AGING, 2007, 24 (02) : 169 - 171
  • [5] Spotlight on Bicalutamide 150mg in the Treatment of Locally Advanced Prostate Cancer
    Keri Wellington
    Susan J. Keam
    Drugs & Aging, 2007, 24 : 169 - 171
  • [6] Place of bicalutamide 150mg in the treatment of prostate cancer: 3rd analysis of the EPC (Early prostate cancer) programme
    Fourcade, Richard-Olivier
    Richaud, Pierre
    Coloby, Patrick
    PROGRES EN UROLOGIE, 2007, 17 (04): : 891 - 899
  • [7] Re: Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
    Jocham, Dieter
    EUROPEAN UROLOGY, 2007, 52 (02) : 609 - 610
  • [8] Salvage Therapy With Bicalutamide 150 mg in Nonmetastatic Castration-resistant Prostate Cancer
    Lodde, Michele
    Lacombe, Louis
    Fradet, Yves
    UROLOGY, 2010, 76 (05) : 1189 - 1193
  • [9] Bicalutamide 150 mg as secondary hormonal therapy for castration-resistant prostate cancer
    Su-bo Qian
    Hai-bo Shen
    Qi-feng Cao
    Lin Zhang
    Yi-fan Chen
    Jun Qi
    International Urology and Nephrology, 2015, 47 : 479 - 484
  • [10] Bicalutamide 150 mg as secondary hormonal therapy for castration-resistant prostate cancer
    Qian, Su-bo
    Shen, Hai-bo
    Cao, Qi-feng
    Zhang, Lin
    Chen, Yi-fan
    Qi, Jun
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (03) : 479 - 484
12345